Original Article

You have full text access to this OnlineOpen article

Developing a cancer-specific geriatric assessment†

A feasibility study

  1. Arti Hurria M.D.1,‡,§,*,
  2. Supriya Gupta M.D.2,
  3. Marjorie Zauderer M.S.3,
  4. Enid L. Zuckerman L.M.S.W., M.A.1,
  5. Harvey J. Cohen M.D.4,
  6. Hyman Muss M.D.5,
  7. Miriam Rodin M.D., Ph.D.2,
  8. Katherine S. Panageas Dr.P.H.1,
  9. Jimmie C. Holland M.D.1,
  10. Leonard Saltz M.D.1,
  11. Mark G. Kris M.D.1,
  12. Ariela Noy M.D.1,
  13. Jorge Gomez M.D.1,
  14. Ann Jakubowski M.D., Ph.D.1,
  15. Clifford Hudis M.D.1,
  16. Alice B. Kornblith Ph.D.6

Article first published online: 4 OCT 2005

DOI: 10.1002/cncr.21422

Issue

Cancer

Cancer

Volume 104, Issue 9, pages 1998–2005, 1 November 2005

Additional Information

How to Cite

Hurria, A., Gupta, S., Zauderer, M., Zuckerman, E. L., Cohen, H. J., Muss, H., Rodin, M., Panageas, K. S., Holland, J. C., Saltz, L., Kris, M. G., Noy, A., Gomez, J., Jakubowski, A., Hudis, C. and Kornblith, A. B. (2005), Developing a cancer-specific geriatric assessment. Cancer, 104: 1998–2005. doi: 10.1002/cncr.21422

Author Information

  1. 1

    Department of Medicine, Psychiatry and Behavioral Sciences, and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York

  2. 2

    Department of Medicine, University of Chicago, Chicago, Illinois

  3. 3

    College of Physicians and Surgeons, Columbia University, New York, New York

  4. 4

    Center for the Study of Aging, Durham Veterans Affairs Medical Center and Duke University, Durham, North Carolina

  5. 5

    Department of Medicine, University of Vermont, Burlington, Vermont

  6. 6

    Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts

  1. ‡

    During the current study, Dr. Hurria's salary was supported by the American Society of Clinical Oncology Young Investigator Award and the American Federation for Aging Research.

  2. §

    Fax: (212) 717-3821

*Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021

  1. †

    Presented at the 40th annual meeting of the American Society of Clinical Oncology, New Orleans, Louisiana, June 5–8, 2004.

Publication History

  1. Issue published online: 17 OCT 2005
  2. Article first published online: 4 OCT 2005
  3. Manuscript Accepted: 16 MAY 2005
  4. Manuscript Revised: 23 MAR 2005
  5. Manuscript Received: 13 DEC 2004

Funded by

  • Memorial Sloan-Kettering Cancer Center (MSKCC) Patrick Byrne Research Fund
  • MSKCC NIH P20

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (97K)

REFERENCES

  • 1
    Narain P, Rubenstein LZ, Wieland GD, et al. Predictors of immediate and 6 month outcomes in hospitalized elderly patients. The importance of functional status. J Am Geriatr Soc. 1988; 36: 775–783.
  • 2
    Reuben DB, Rubenstein LV, Hirsch SH, Hays RD. Value of functional status as a predictor of mortality: results of a prospective study. Am J Med. 1992; 93: 663–669.
  • 3
    Extermann M, Overcash J, Lyman GH, Parr J, Balducci L. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol. 1998; 16: 1582–1587.
  • 4
    Landi F, Zuccala G, Gambassi G, et al. Body mass index and mortality among older people living in the community. J Am Geriatr Soc. 1999; 47: 1072–1076.
  • 5
    Dewys WD, Begg, C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med. 1980; 68: 491–497.
  • 6
    Newman AB, Yanez D, Harris T, et al. Weight change in old age and its association with mortality. J Am Geriatr Soc. 2001; 49: 1309–1318.
    Direct Link:
  • 7
    Eagles JM, Beattie JAG, Restall DB, et al. Relationship between cognitive impairment and early death in the elderly. BMJ. 1990; 300: 239–240.
  • 8
    Wolfson C, Wolfson, DB, Asgharian M, et al. A reevaluation of the duration of survival after the onset of dementia. N Engl J Med. 2001; 344: 1111–1116.
  • 9
    Seeman TE, Berkman LF, Kohout F, Lacroix A, Glynn R, Blazer D. Intercommunity variations in the association between social ties and mortality in the elderly. A comparative analysis of three communities. Ann Epidemiol. 1993; 3: 325–335.
  • 10
    Stuck AE, Siu AL, Wieland GD, Adams J, Rubenstein LZ. Comprehensive geriatric assessment: a meta-analysis of controlled trials. Lancet. 1993; 342: 1032–1036.
  • 11
    Cohen HJ, Feussner JR, Weinberger M, et al. A controlled trial of inpatient and outpatient geriatric evaluation and management. N Engl J Med. 2002; 346: 905–912.
  • 12
    Fillenbaum GG, Smyer MA. The development, validity, and reliability of the OARS Multidimensional Functional Assessment Questionnaire. J Gerontol. 1981; 36: 428–434.
  • 13
    Stewart AL, Kamberg CJ. Physical functioning measures. In: StewartAL, WareJEJr., editors. Measuring functioning and well-being; the Medical Outcomes Study approach. Durham, NC: Duke University Press, 1992: 86–101.
  • 14
    Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacleodCM, editor. Evaluation of chemotherapeutic agents. New York: Columbia University Press, 1948: 191–205.
  • 15
    Yates JW, Chalmer B, McKegney FP. Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer. 1980; 45: 2220–2224.
    Direct Link:
  • 16
    Loprinzi CL, Laurie JA, Wieand S, et al. Prospective evaluation of prognostic variables from patient-completed questionnaires. J Clin Oncol. 1994; 12: 601–607.
  • 17
    Podsiadlo D, Richardson S. The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991; 39: 142–148.
  • 18
    Guralnik JM, Ferrucci L, Pieper CF, et al. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. J Gerontol A Biol Sci Med Sci. 2000; 55: M221–231.
  • 19
    Naeim A, Reuben D. Geriatric syndromes and assessment in older cancer patients. Oncology. 2001; 15: 1567–1577.
  • 20
    Kawas C, Karagiozis H, Resau L, Corrada M, Brookmeyer R. Reliability of the Blessed Telephone Information-Memory-Concentration Test. J Geriatr Psychiatry Neurol. 1995; 8: 238–242.
  • 21
    Katzman R, Brown T, Fuld P, et al. Validation of a short orientation-memory-concentration test of cognitive impairment. Am J Psychiatry. 1983; 140: 734–739.
  • 22
    Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983; 67: 361–370.
    Direct Link:
  • 23
    Carroll BT, Kathol RG, Noyes R, Wald TG, Clamon GH. Screening for depression and anxiety in cancer patients using the Hospital Anxiety and Depression Scale. Gen Hosp Psychiatry. 1993; 15: 69–74.
  • 24
    Hopwood P, Howell A, Maguire P. Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two self-report questionnaires. Br J Cancer. 1991; 64: 353–356.
  • 25
    Razavi D, Delvaux N, Farvacques C, Robaye E. Screening for adjustment disorders and major depressive disorders in cancer patients. Br J Psychiatry. 1990; 156: 79–83.
  • 26
    Ibbotson T, Maguire P, Selby P, Priestman T, Wallace L. Screening for anxiety and depression in cancer patients: the effects of disease and treatment. Eur J Cancer. 1994; 30A: 37–40.
  • 27
    Stewart AL, Ware JE Jr. Measuring functioning and well-being: the Medical Outcomes Study approach. Durham, NC: Duke University Press, 1992.
  • 28
    Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991; 32: 705–714.
  • 29
    Balducci L. The geriatric cancer patient: equal benefit from equal treatment. Cancer Control. 2001; 8(2 Suppl. ): 1–25.
  • 30
    Ingram SS, Seo PH, Martell RE, et al. Comprehensive assessment of the elderly cancer patient: the feasibility of self-report methodology. J Clin Oncol. 2002; 20: 770–775.
View Full Article (HTML) Get PDF (97K)